Fund HoldingsSarissa Capital Management LP

Total Portfolio Value
$322.86M
Total Bought
$2.78M
Total Sold
$69.79M
Net Transaction
-$67.01M
Filing Period:
Securities
SharesValue ($K)
Q3 2024
Q4 2024
Change
Q3 2024
Q4 2024
Weight (%)
Change
IRONWOOD PHARMACEUTICALS INC16,390,00016,390,000067,52772,60822.49%+5,081
LANTHEUS HLDGS INC(LNTH)26,00063,000+37,0002,8545,6361.75%+2,782
VOR BIOPHARMA INC(VOR)618,000618,00004336860.21%+253
REGULUS THERAPEUTICS INC185,1830-185,1832910-291
AMARIN CORP PLC24,850,62324,850,623015,57912,0533.73%-3,526
NEUROCRINE BIOSCIENCES INC(NBIX)410,483309,116-101,36747,29642,19413.07%-5,102
BIOGEN INC(BIIB)26,9500-26,9505,2240-5,224
INNOVIVA INC(INVA)7,277,0007,277,0000140,519126,25639.11%-14,263
CYTOKINETICS INC(CYTK)1,110,000833,799-276,20158,60839,22212.15%-19,386
GILEAD SCIENCES INC(GILD)763,333262,080-501,25363,99824,2087.50%-39,790
Page 1 of 1